Study of Infigratinib in Children With Achondroplasia
Clinical trial NCT04265651 · COMPLETED
Trial details
- NCT number
- NCT04265651
- Sponsor
- QED Therapeutics, a BridgeBio company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-10
- Primary completion
- 2024-10-21
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.